Randomised controlled trial of mesalazine in IBS

OBJECTIVE: Low-grade intestinal inflammation plays a role in the pathophysiology of IBS. In this trial, we aimed at evaluating the efficacy and safety of mesalazine in patients with IBS. DESIGN: We conducted a phase 3, multicentre, tertiary setting, randomised, double-blind, placebo-controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbara, Giovanni, Cremon, Cesare, Annese, Vito, Basilisco, Guido, Bazzoli, Franco, Bellini, Massimo, Benedetti, Antonio, Benini, Luigi, Bossa, Fabrizio, Buldrini, Paola, Cicala, Michele, Cuomo, Rosario, Germanà, Bastianello, Molteni, Paola, Neri, Matteo, Rodi, Marcello, Saggioro, Alfredo, Scribano, Maria Lia, Vecchi, Maurizio, Zoli, Giorgio, Corinaldesi, Roberto, Stanghellini, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Neurogastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717362/
https://www.ncbi.nlm.nih.gov/pubmed/25533646
http://dx.doi.org/10.1136/gutjnl-2014-308188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717362/
https://www.ncbi.nlm.nih.gov/pubmed/25533646
http://dx.doi.org/10.1136/gutjnl-2014-308188

Ejemplares similares